chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Case number PHEH2014US018197 is an initial spontaneous report received from a Healthcare Professional on 09 Sep 2014. This report refers to a 01 year old female infant. Her medical history and concomitant medication were not reported. She was vaccinated with FLUVIRIN (batch number: 145303) intramuscularly on 03 Sep 2014. No adverse event was reported following this administration error.
Red, hot, elevated skin reaction underneath vaccination site, 1 week after receiving vaccine. Associated entire left arm soreness again. (Soreness originally subsided after 3 days, returned 1 week after vaccine)
Patient broke out in rash all over upper body. Patient went to to see the doctor was given a sample of a cream (patient thought antibiotic of some sort). Then was given a steroid taper.
Received Pneumovax 13 25mcg0.5 ml injection into RIGHT deltoid. Pain at injection site soon after. 10/05/22, developed redness and swelling that extended down to elbow, from injection site , around inner arm to elbow. Using ibuprophen, ice, heat for symptom management. Mobility in right arm decreased due to pain and swelling. I also received a flu vaccine the same day in my LEFT deltoid without reaction. Of note, no reaction last year to Prevnar 13 vaccine. Also, no reaction to 4 Moderna CoVid vaccines other than pain at injection site.
11 minutes after receiving shot, scalp on head started itching, tongue started swelling, area around tonsils felt like it was swelling.  Pt received epi, and lips/tongue/throat continued to swell and itching spread to different parts of face.
right away there was pain in the knee, Chills the following day- wearing layers of clothes and still cold, fatigue, weird sensation and aches in arms and legs, under the weather similar to the flu,  headache,
Began to see small red spot just under right breast on April 14 and slowly got more spots. Went to dermatologist on April 19th and told it was Pityriasis Rosea and given a pamphlet on it. The spots are getting larger and itchy and staying mostly on torso with some on neck as of right now. Suggested using OTC steroid cream and provided with a prescription for steroid cream.
Patient called the pharmacy about 630pm stating she had severe, sudden nausea, vomiting and diarrhea beginning about 5p.m. after her second dose of Pfizer. No fever, patient reported the symptoms seemed to have slowed.
diagnosis with COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (diagnosis with COVID-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No medical history information was reported.     On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced COVID-19 (diagnosis with COVID-19). At the time of the report, COVID-19 (diagnosis with COVID-19) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Feb-2021 and was forwarded to Moderna on 03-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (diagnosis with COVID-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No medical history information was reported.     On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced COVID-19 (diagnosis with COVID-19). At the time of the report, COVID-19 (diagnosis with COVID-19) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Patient felt warm this morning, but did not have fever; her arm is tender and sore after receiving the Pfizer vaccine; her arm is tender and sore after receiving the Pfizer vaccine; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the parent. Other Case identifier(s): 146400 (Moderna), MOD22-020994 (Moderna), U1076693 (Moderna).  A female patient received BNT162b2 (BNT162B2), on 13Aug2022 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: moderna coviD-19 vaccine (DOSE 1, SINGLE, Batch Number: 064A22A, Dose Form: Injection, Dose Unit Route: Intramuscular), administration date: 15Jul2022, for COVID-19 immunization, reaction(s): "did not have any adverse reactions". The following information was reported: PAIN IN EXTREMITY (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 13Aug2022, outcome "unknown" and all described as "her arm is tender and sore after receiving the Pfizer vaccine"; FEELING HOT (non-serious) with onset 15Aug2022, outcome "unknown", described as "Patient felt warm this morning, but did not have fever".  Additional information: Caller was a registered nurse but was calling to ask a question for her daughter. She stated that her daughter received a mixed primary series. Her 1st dose was the Moderna COVID-19 vaccine, administered on 15Jul2022. Her 2nd dose was the Pfizer COVID-19 vaccine, administered on 13Aug2022. The patient did not have any adverse reactions from the 1st dose of Moderna. However, her arm was tender and sore after receiving the Pfizer vaccine. Patient also felt warm this morning, but did not have a fever. Patient was not on any concomitant medications. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
like having the flu; not feeling well; fatigue; muscle pain; joint pain; chills; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (like having the flu), MALAISE (not feeling well), FATIGUE (fatigue), MYALGIA (muscle pain) and ARTHRALGIA (joint pain) in a 66-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension.    On 30-Sep-2023 at 3:00 PM, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In 2023, the patient experienced INFLUENZA LIKE ILLNESS (like having the flu), MALAISE (not feeling well), FATIGUE (fatigue), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and CHILLS (chills). At the time of the report, INFLUENZA LIKE ILLNESS (like having the flu), MALAISE (not feeling well), FATIGUE (fatigue), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and CHILLS (chills) had not resolved.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-Oct-2023: Live Follow up received contains no new information.
asthmatic like attack 45min p/vax fatigue, pulse rate inc, skin very warm to touch reported by mom;MD notified by mom rx for inhaler;
21 x 23 cm pink indurated area - Lateral upper arm to dorsal and ventral aspect - 250 - 270 degree.
Sore throat developing into severe sinus and chest cold.  Still recovering as of 12/13/2009.
Day after 2nd dose, 4-15, experienced fever,  headache, muscle ache, and tiredness. 2nd day after 2nd dose, had slight fever and slight headache. As of 4-17, have been experiencing mild headaches every day, from mid morning to early evening. Rarely if ever had headaches prior to 2nd covid-19 vaccination.
Patient developed severe leg pain and presented to the emergency room. She was diagnosed with a deep vein thrombosis
New onset elevated blood pressure post booster shot. Similar response after first two injections but not as severe.
pt recv vax & w/in several days p/vax pt exp arthralgia, n/v & fever;pt was seen in ER 2JUL96;rheumatoid arthritis w/u apparently was negative, pt given ibuprofen for relief;pt seen again for joint pain 4JUL96;
severe arm pain; Fever; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EL3249) via an unspecified route of administration in left arm on 20Jan2021 09:45 at single dose for Covid-19 immunization. Medical history included high blood pressure; thyroid disease; high cholesterol; prior stroke; prior to vaccination, the patient was diagnosed with COVID-19. No allergies to medications, food, or other products. The patient's concomitant medications were not reported. The patient experienced severe arm pain and fever on 20Jan2021 14:30. No treatment received for the adverse events. This is a non-serious report. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovered in Jan2021.
This spontaneous report as received from a health professional refers to a 12 month old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 16-NOV-2015, the patient was vaccinated with an improperly stored dose of (Oka/Merck) VARIVAX lot # L024256, expiration date: 01-JUL-2017 (exact dose and route of administration were not reported). The temperature excursion of the administered dose of vaccine was 20.3 degrees Fahrenheit for 72 hours. Data logger was involved. There were no previous excursions reported. There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Soreness, redness, 10/30/2015 temp of 102.9, 10/31/2015 continued temp, shortness of breath, unable to move arm, red and swollen. Admitted to hospital 10/31/2015, treated for possible cellulitis with vancomycin by 11/02/2015 kidneys going into renal failure, stopped vancomycin and any thing else affecting kidneys. Kidneys continued to worsen also treated with Benadryl for allergic reaction. Determined no cellulitis just allergic reaction, acute renal failure, remained in hospital treating allergic reaction and renal failure until 11/15/2015 when kidneys were now on a downward trend and repairing themselves. Signs of allergic reaction are also gone. As of 11/24/2015, still at home resting on renal diet. Unable to work now for over 3 weeks due to flu vaccine. Also pneumonia shot given at the same time, I have had this before about 20 years ago. I have never received a flu vaccine before.
Redness on the injection site; Swelling on the injection site; A report was received from a healthcare professional concerning a 44 year old female patient who was participating in a mRNA-1273 Program and developed redness and swelling at the injection site.   The patient's medical history and relevant concomitant medications were not reported.   On 31 Dec 2020, approximately eight days prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the [left arm] for prophylaxis of COVID-19 infection.   The patient experienced redness and swelling at the injection site on the morning of 08 Jan 2021.  The patient treated the event with acetaminophen.  Action taken with mRNA-1273 in response to the events was not reported .   The outcome of the events redness and swelling at the injection site were not reported.  Reporter causality for the events was not provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Information has been received from a registered nurse concerning a patient who on an unspecified date was vaccinated with an unspecified dose of ROTATEQ vaccine live (human-bovine). It was noted that the patient spit most of "it" up. At the time if the report, the patient's status was unknown. There was no product quality complaint involved. This is one of several reports from the same source. Additional information has been requested. This is in follow-up to report(s) previously submitted on 08/14/2008. Information has been received from a registered nurse concerning a patient who on an unspecified date was vaccinated with an unspecified dose of ROTATEQ. It was noted that the patient spit most of "it" up. At the time if the report, the patient's status was unknown. There was no product quality complaint involved. This is one of several reports from the same source. Additional information has been requested.
"Chest tightness" starting 2 days after vaccine administration (1-22-18) and continuing until 1-26-18. Advised patient to consult Doctor.
I received my first Gardasil vaccine Sept. 12, 2007 and reluctantly received my second one on Nov. 12, 2007. I also had blood work done while I was at the Dr's. office Sept. 12, 2007 which came back completely normal. On Sept. 30, 2007 I began to have horrible pain in my lower abdomen (mainly my ovaries). I then began having irregular periods-to every extreme of irregular. The timing is off-way off, the flow is extremely heavy-I have clots in my blood now, the length of my periods has almost doubled, the pain is so severe-I can not even get out of bed half of the time, I began having nausea and vomiting, headaches, fever, diarrhea, dizziness, aneamia, weight gain, and major pain in the joint of the middle toe on my left foot. These symptoms have not subsided since Sept. 30th. I made a visit to my gynecologist  and reported the symptoms and told him that I think it is linked with the vaccine and he said that it was just a coincidence and acted like it was no big deal. I have had 8 periods from Sept. 30th-Dec. 7th-to me that is a big deal. I had to go to the emergency room Nov. 18th, 2007 because the symptoms and bleeding were so severe-the e.r. doctor did blood work and said my blood count was pretty low and that I was aneamic and told me to begin iron supplements. He also gave me prescriptions for ibuprofen, provera, and phenergan and told me to see my gyno asap. I did not take the provera. I got in with my gynecologist two days later and he still acted like it was not a big deal. He did an ultrasound and put me on birth control. Since then I have still not gotten any relief and I made a call to his office two days ago to let them know and his nurse told me that if it is not better by Mon. (Dec. 10th) to call back. It is now Friday (Dec. 7th,2007)and my period is just as heavy and painful today as it was last Monday (Dec. 3rd). I have NEVER had ANY health concerns and I have never been sexually active, I am a virgin-so I thought the vaccine would be beneficial for me. I think I made a major mistake by getting this vaccine. I now have major concerns about my current health. I am worried and scared that I may never be able to have children and that this is going to do permanent damage. I have NEVER had any irregular periods in all of my years of having them. I really hate that this is happening to me and that no one can give me any answers-but most of all I would hate for this to happen to others. I have a strong feeling that Gardasil is the cause of all of my problems because I have discovered some people that have the same symptoms that have received this vaccine. This needs to be researched. Please help me.
Extreme body aches, dizziness, fever of 101 degrees (so far), headache, chills.
CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/20/2022 GI HEMORRHAGE
Pt. in 2nd trimester received vaccine. OB MD notified. Pt. brought in and counseled and will be closely monitored during pregnancy.
developed sx of URI 1/17/22- tested negative at physician office tested positive 1/18/22 on binax rapid antigen test fully vax w/ Moderna- no booster
I received flu shot on my left upper arm on 10/2/17 and later that evening noticed site is reddened, raised, hardened with a bleb wheel and painful to touch. I am not allergic to eggs, fish or latex.
Initial unsolicited report received from a nurse via partner company (Pfizer) (under manufacturer report number- 2016032624) on 02 February 2016. This case involves a patient (age and gender not reported) who was vaccinated with a dose of DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (Tdap), PNEUMOCOCCAL (POLYSACCHARIDE) (23 SEROTYPES) VACCINE (Pneumovax 23) and PNEUMOCOCCAL POLYSACCHARIDE VACCINE (Prevnar) (batch number, route and site of administration not reported) on an unspecified date. The patient's medical history and concomitant medications were not reported. On an unspecified date, following the vaccination, the patient had experienced allergy to Tdap vaccine and significant swelling. Laboratory data and corrective treatment were not reported. The outcome of event was not reported. List of documents held by sender: none.
Patient was 17 years at time of administration of a vaccine authorized for individuals 18+. Notably, received vaccine 30 days prior to turning 18.
CHILLS, GENERALIZED MYALGIAS, HEADACHE, NAUSEA, FATIGUE SYMPTOMS STARTED 12 HOURS AFTER RECEIVING SECOND DOSE AND LASTED 36 HOURS. MILD FEELING OF MALAISE FOR ABOUT 48 HOURS AFTER SECOND DOSE.
Patient developed rash on arms starting about 1 hour post-vaccination. Described rash as really red, bumpy, and slightly itchy; worse on right arm (vaccinated arm). Self-treated with benadryl.
Pulmonary embolism with onset 1-2 days following 2nd dose of Moderna vaccination. No other precipitating events found
shingles; This spontaneous report has been received from a lawyer regarding a case in litigation, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided. In 2014, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (strength, lot #, expiration date, dosage, anatomical location and route of administration were not provided ), as prescribed and/or administered by a pharmacist at pharmacy, for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to vaccination, the patient was treated by a healthcare provider at clinic/hospital for shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) use, the patient had and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of shingles was not provided.
This spontaneous report was received from a nurse and refers to an unspecified number of patients of unknown age and genders. No medical history, concurrent conditions and concomitant therapies were reported. On unknown dates, the patients received improperly stored GARDASIL (lot #, expiration date, dose and route of administration were not reported). No adverse effects were reported. No PQC (product quality complaint) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
unspecified 14 week old patient received "first dose" of ROTATEQ; This spontaneous report was received from a physician via a company representative and refers to a 14-week-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On an unknown date, the 14-week-old patient was vaccinated with the first dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally (dose, lot # and expiration date were not reported) for prophylaxis (product administered to patient of inappropriate age).
Eleven days after receiving my vaccine, I had spent the morning walking a mile and a half and had done over 100 step-ups on my back steps. I made lunch and everything was great. I was reading a book and I went to stand up and felt very dizzy. I took my Blood Pressure, and it was 145/ and it's normally 110. My heart rate was normal through this. I took Tylenol and started to feel better. The next morning, I woke up and I was sweating. It was a cold sweat, and I didn't feel right. I called my PCP, and they told me to go a local ER. The doctors did a CAT scan and blood work which came back normal. They made me stay the night to have an MRI in the morning. All tests came back normal. They wanted me to take aspirin and a statin, but I told them that I am allergic. They wanted me to take Plavix, but it wasn't working well for me. I had the same experience after receiving my second dose. I wish I would have never gotten the vaccine.
Client reports being "very sick" the next day with vomiting and headache.  She has a history of having COVID 19  on 12/25/2020.
Nausea, joint pain in hands, feet, knees, etc. Vomitting, dry heaving, insomnia, chest pain, inflammation of joints. Symptoms still occur daily several months later (09/03). Patient has never been sick in his life prior.) The 60 day follow up received on 12/12/03 states joint pain in feet, knees, arms and hands. Nausea. Eyes ache making it difficult to see. Chest pains. Stomach pains. Vomiting. Insomnia. Sinusitis. Pt did not have any sickness of this type prior to taking the shot.
high pitched ringing in the ear; This spontaneous case was reported by a non-health professional and describes the occurrence of TINNITUS (high pitched ringing in the ear) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (high pitched ringing in the ear). At the time of the report, TINNITUS (high pitched ringing in the ear) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment reported   This case was linked to MOD-2022-452691 (Patient Link).
This spontaneous report as received from a medical assistant (M.A.) refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 28-OCT-2015, the patient was vaccinated with the third dose of improperly stored ROTATEQ oral liquid (lot # L008574, expiration date 22-NOV-2016) (dose unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Burning at injection site.  Headaches. I was in menopause and now I have had two periods with heavy flow since the shot.